Pulmonary Inflammation Impacts on CYP1A1-Mediated Respiratory Tract DNA Damage Induced by the Carcinogenic Air Pollutant Benzo[a]pyrene
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
14329
Cancer Research UK - United Kingdom
101 126/B/13/Z
Wellcome Trust - United Kingdom
C313/A14329
Cancer Research UK - United Kingdom
101 126/Z/12/Z
Wellcome Trust - United Kingdom
PubMed
25911668
PubMed Central
PMC4517052
DOI
10.1093/toxsci/kfv086
PII: kfv086
Knihovny.cz E-zdroje
- Klíčová slova
- DNA adducts, benzo[a]pyrene, bronchoalveolar lavage, carcinogen metabolism, cytochrome P450, pulmonary inflammation,
- MeSH
- benzopyren toxicita MeSH
- cytochrom P-450 CYP1A1 metabolismus MeSH
- dýchací soustava metabolismus patologie MeSH
- karcinogeny toxicita MeSH
- látky znečišťující vzduch toxicita MeSH
- myši inbrední C57BL MeSH
- myši MeSH
- pneumonie enzymologie MeSH
- poškození DNA * MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- benzopyren MeSH
- CYP1A1 protein, human MeSH Prohlížeč
- cytochrom P-450 CYP1A1 MeSH
- karcinogeny MeSH
- látky znečišťující vzduch MeSH
Pulmonary inflammation can contribute to the development of lung cancer in humans. We investigated whether pulmonary inflammation alters the genotoxicity of polycyclic aromatic hydrocarbons (PAHs) in the lungs of mice and what mechanisms are involved. To model nonallergic acute inflammation, mice were exposed intranasally to lipopolysaccharide (LPS; 20 µg/mouse) and then instilled intratracheally with benzo[a]pyrene (BaP; 0.5 mg/mouse). BaP-DNA adduct levels, measured by (32)P-postlabeling analysis, were approximately 3-fold higher in the lungs of LPS/BaP-treated mice than in mice treated with BaP alone. Pulmonary Cyp1a1 enzyme activity was decreased in LPS/BaP-treated mice relative to BaP-treated mice suggesting that pulmonary inflammation impacted on BaP-induced Cyp1a1 activity in the lung. Our results showed that Cyp1a1 appears to be important for BaP detoxification in vivo and that the decrease of pulmonary Cyp1a1 activity in LPS/BaP-treated mice results in a decrease of pulmonary BaP detoxification, thereby enhancing BaP genotoxicity (ie, DNA adduct formation) in the lung. Because less BaP was detoxified by Cyp1a1 in the lungs of LPS/BaP-treated mice, more BaP circulated via the blood to extrapulmonary tissues relative to mice treated with BaP only. Indeed, we observed higher BaP-DNA adduct levels in livers of LPS/BaP-treated mice compared with BaP-treated mice. Our results indicate that pulmonary inflammation could be a critical determinant in the induction of genotoxicity in the lung by PAHs like BaP. Cyp1a1 appears to be involved in both BaP bioactivation and detoxification although the contribution of other enzymes to BaP-DNA adduct formation in lung and liver under inflammatory conditions remains to be explored.
Zobrazit více v PubMed
Arlt V. M., Poirier M. C., Sykes S. E., John K., Moserova M., Stiborova M., Wolf C. R., Henderson C. J., Phillips D. H. (2012). Exposure to benzo[a]pyrene of hepatic cytochrome P450 reductase null (HRN) and P450 reductase conditional null (RCN) mice: detection of benzo[a]pyrene diol epoxide-DNA adducts by immunohistochemistry and 32P-postlabelling. Toxicol. Lett. 213, 160–166. PubMed PMC
Arlt V. M., Stiborova M., Henderson C. J., Thiemann M., Frei E., Aimova D., Singh R., Gamboa da Costa G., Schmitz O. J., Farmer P. B., et al. (2008). Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice. Carcinogenesis 29, 656–665. PubMed
Arlt V. M., Zuo J., Trenz K., Roufosse C. A., Lord G. M., Nortier J. L., Schmeiser H. H., Hollstein M., Phillips D. H. (2011). Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice. Int. J. Cancer 128, 21–32. PubMed
Attfield M. D., Schleiff P. L., Lubin J. H., Blair A., Stewart P. A., Vermeulen R., Coble J. B., Silverman D. T. (2012). The Diesel Exhaust in Miners Study: a cohort mortality study with emphasis on lung cancer. J. Natl. Cancer Inst. 104, 869–883. PubMed PMC
Baird W. M., Hooven L. A., Mahadevan B. (2005). Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ. Mol. Mutagen. 45, 106–114. PubMed
Borm P. J., Knaapen A. M., Schins R. P., Godschalk R. W., Schooten F. J. (1997). Neutrophils amplify the formation of DNA adducts by benzo[a]pyrene in lung target cells. Environ. Health Perspect. 105(Suppl. 5), 1089–1093. PubMed PMC
Brody J. S., Spira A. (2006). State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc. Am. Thorac. Soc. 3, 535–537. PubMed
El-Kadi A. O., Bleau A. M., Dumont I., Maurice H., du Souich P. (2000). Role of reactive oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction. Drug Metab Dispos. 28, 1112–1120. PubMed
Friedberg E. C. (2001). How nucleotide excision repair protects against cancer. Nat. Rev. 1, 22–33. PubMed
Grivennikov S. I., Greten F. R., Karin M. (2010). Immunity, inflammation, and cancer. Cell 140, 883–899. PubMed PMC
Gungor N., Haegens A., Knaapen A. M., Godschalk R. W., Chiu R. K., Wouters E. F., van Schooten F. J. (2010a). Lung inflammation is associated with reduced pulmonary nucleotide excision repair in vivo. Mutagenesis 25, 77–82. PubMed
Gungor N., Pennings J. L., Knaapen A. M., Chiu R. K., Peluso M., Godschalk R. W., Van Schooten F. J. (2010b). Transcriptional profiling of the acute pulmonary inflammatory response induced by LPS: role of neutrophils. Respir. Res. 11, 24. PubMed PMC
Hashimoto A. H., Amanuma K., Hiyoshi K., Takano H., Masumura K., Nohmi T., Aoki Y. (2005). In vivo mutagenesis induced by benzo[a]pyrene instilled into the lung of gpt delta transgenic mice. Environ. Mol. Mutagen . 45, 365–373. PubMed
Holand T., Riffo-Vasquez Y., Spina D., O'Connor B., Woisin F., Sand C., Marber M., Bacon K. B., Rohlff C., Page C. P. (2014). A role for mitogen kinase kinase 3 in pulmonary inflammation validated from a proteomic approach. Pulm. Pharmacol. Ther. 27, 156–163. PubMed
IARC (2010). Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. IARC Monogr. Eval. Carcinog. Risks Hum. 92, 1–853. PubMed PMC
IARC (2013). Diesel and gasoline engine exhaust and some nitroarenes. IARC Monogr. Eval. Carcinog. Risks Hum. 105, 1–703. PubMed PMC
Joseph P., Jaiswal A. K. (1994). NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc. Natl. Acad. Sci. USA 91, 8413–8417. PubMed PMC
Joseph P., Jaiswal A. K. (1998). NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones. Br. J. Cancer 77, 709–719. PubMed PMC
Karuzina I. I., Archakov A. I. (1994a). Hydrogen peroxide-mediated inactivation of microsomal cytochrome P450 during monooxygenase reactions. Free Radic. Biol. Med. 17, 557–567. PubMed
Karuzina I. I., Archakov A. I. (1994b). The oxidative inactivation of cytochrome P450 in monooxygenase reactions. Free Radic. Biol. Med. 16, 73–97. PubMed
Ke S., Rabson A. B., Germino J. F., Gallo M. A., Tian Y. (2001). Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide. J. Biol. Chem. 276, 39638–39644. PubMed
Kelly F. J., Fussell J. C. (2011). Air pollution and airway disease. Clin. Exp. Allergy 41, 1059–1071. PubMed
Knaapen A. M., Gungor N., Schins R. P., Borm P. J., Van Schooten F. J. (2006). Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 21, 225–236. PubMed
Krais A. M., Mühlbauer K.-R., Kucab J. E., Chinbuah H., Cornelius M. G., Wei Q.-X., Hollstein M., Phillips D. H., Arlt V. M., Schmeiser H. H. (2015). Comparison of the metabolic activation of environmental carcinogens in mouse embryonic stem cells and mouse embryonic fibroblasts. Toxicol. in vitro 29, 34–43. PubMed PMC
Kucab J. E., Phillips D. H., Arlt V. M. (2012). Metabolic activation of diesel exhaust carcinogens in primary and immortalized human TP53 knock-in (Hupki) mouse embryo fibroblasts. Environ. Mol. Mutagen. 53, 207–217. PubMed
Langie S. A., Knaapen A. M., Brauers K. J., van Berlo D., van Schooten F. J., Godschalk R. W. (2006). Development and validation of a modified comet assay to phenotypically assess nucleotide excision repair. Mutagenesis 21, 153–158. PubMed
Loomis D., Grosse Y., Lauby-Secretan B., El Ghissassi F., Bouvard V., Benbrahim-Tallaa L., Guha N., Baan R., Mattock H., Straif K., et al. . (2013). The carcinogenicity of outdoor air pollution. Lancet Oncol. 14, 1262–1263. PubMed
Martin F. L., Patel I. I., Sozeri O., Singh P. B., Ragavan N., Nicholson C. M., Frei E., Meinl W., Glatt H., Phillips D. H., et al. (2010). Constitutive expression of bioactivating enzymes in normal human prostate suggests a capability to activate pro-carcinogens to DNA-damaging metabolites. Prostate 70, 1586–1599. PubMed
Medan D., Wang L., Yang X., Dokka S., Castranova V., Rojanasakul Y. (2002). Induction of neutrophil apoptosis and secondary necrosis during endotoxin-induced pulmonary inflammation in mice. J. Cell Physiol. 191, 320–326. PubMed
Mizerovska J., Dracinska H., Frei E., Schmeiser H. H., Arlt V. M., Stiborova M. (2011). Induction of biotransformation enzymes by the carcinogenic air-pollutant 3-nitrobenzanthrone in liver, kidney and lung, after intra-tracheal instillation in rats. Mutat. Res. 720, 34–41. PubMed
Morel Y., Barouki R. (1998). Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1. J. Biol. Chem. 273, 26969–26976. PubMed
Morel Y., Barouki R. (1999). Repression of gene expression by oxidative stress. Biochem. J. 342(Pt 3), 481–496. PubMed PMC
Moriya N., Kataoka H., Fujino H., Nishikawa J., Kugawa F. (2012). Effect of lipopolysaccharide on the xenobiotic-induced expression and activity of hepatic cytochrome P450 in mice. Biol. Pharm. Bull. 35, 473–480. PubMed
Nebert D. W., Shi Z., Galvez-Peralta M., Uno S., Dragin N. (2013). Oral benzo[a]pyrene: understanding pharmacokinetics, detoxication, and consequences—Cyp1 knockout mouse lines as a paradigm. Mol. Pharmacol. 84, 304–313. PubMed PMC
Park J. H., Mangal D., Frey A. J., Harvey R. G., Blair I. A., Penning T. M. (2009) Aryl hydrocarbon receptor facilitates DNA strand breaks and 8-oxo-2'-deoxyguanosine formation by the aldo-keto reductase product benzo[a]pyrene-7,8-dione. J. Biol. Chem. 284, 29725–29734. PubMed PMC
Petruska J. M., Mosebrook D. R., Jakab G. J., Trush M. A. (1992). Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis 13, 1075–1081. PubMed
Phillips D. H. (2005). Macromolecular adducts as biomarkers of human exposure to polycyclic aromatic hydrocarbons. In The Carcinogenic Effects of Polycyclic Aromatic Hydrocarbons (Luch A., Ed.), pp. 137–169. Imperial College Press, London.
Phillips D. H., Arlt V. M. (2007). The 32P-postlabeling assay for DNA adducts. Nat. Protoc. 2, 2772–2781. PubMed
Phillips D. H., Arlt V. M. (2014). 32P-postlabeling analysis of DNA adducts. Methods Mol Biol. 1105, 127–138. PubMed
Purohit V., Basu A. K. (2000). Mutagenicity of nitroaromatic compounds. Chem. Res. Toxicol. 13, 673–692. PubMed
Schottenfeld D., Beebe-Dimmer J. (2006). Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J. Clin. 56, 69–83. PubMed
Schwarze P. E., Totlandsdal A. I., Lag M., Refsnes M., Holme J. A., Ovrevik J. (2013). Inflammation-related effects of diesel engine exhaust particles: studies on lung cells in vitro. BioMed Res. Int. 2013, 685142. PubMed PMC
Shen J., Barrios R. J., Jaiswal A. K. (2010). Inactivation of the quinone oxidoreductases NQO1 and NQO2 strongly elevates the incidence and multiplicity of chemically induced skin tumors. Cancer Res. 70, 1006–1014. PubMed PMC
Shimizu Y., Nakatsuru Y., Ichinose M., Takahashi Y., Kume H., Mimura J., Fujii-Kuriyama Y., Ishikawa T. (2000). Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 97, 779–782. PubMed PMC
Silverman D. T., Samanic C. M., Lubin J. H., Blair A. E., Stewart P. A., Vermeulen R., Coble J. B., Rothman N., Schleiff P. L., Travis W. D., et al. . (2012). The Diesel Exhaust in Miners Study: a nested case-control study of lung cancer and diesel exhaust. J. Natl. Cancer Inst. 104, 855–868. PubMed PMC
Smerdova L., Neca J., Svobodova J., Topinka J., Schmuczerova J., Kozubik A., Machala M., Vondracek J. (2013) Inflammatory mediators accelerate metabolism of benzo[a]pyrene in rat alveolar type II cells: the role of enhanced cytochrome P450 1B1 expression. Toxicology 314, 30–38. PubMed
Smerdova L., Svobodova J., Kabatkova M., Kohoutek J., Blazek D., Machala M., Vondracek J. (2014). Upregulation of CYP1B1 expression by inflammatory cytokines is mediated by the p38 MAP kinase signal transduction pathway. Carcinogenesis 35, 2534–2543. PubMed
Stiborova M., Barta F., Levova K., Hodek P., Frei E., Arlt V. M., Schmeiser H. H. (2014). The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats. Arch Toxicol. Sep 11 [Epub ahead of print]. PubMed
Stiborova M., Dracinska H., Hajkova J., Kaderabkova P., Frei E., Schmeiser H. H., Soucek P., Phillips D. H., Arlt V. M. (2006). The environmental pollutant and carcinogen 3-nitrobenzanthrone and its human metabolite 3-aminobenzanthrone are potent inducers of rat hepatic cytochromes P450 1A1 and -1A2 and NAD(P)H:quinone oxidoreductase. Drug Metab. Dispos. 34, 1398–1405. PubMed
Stiborova M., Frei E., Arlt V. M., Schmeiser H. H. (2014) Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid. Xenobiotica 44, 135–145. PubMed
Stiborova M., Levova K., Barta F., Shi Z., Frei E., Schmeiser H. H., Nebert D. W., Phillips D. H., Arlt V. M. (2012) Bioactivation versus detoxication of the urothelial carcinogen aristolochic acid I by human cytochrome P450 1A1 and 1A2. Toxicol. Sci. 125, 345–358. PubMed PMC
Stiborova M., Martinek V., Svobodova M., Sistkova J., Dvorak Z., Ulrichova J., Simanek V., Frei E., Schmeiser H. H., Phillips D. H., et al. (2010). Mechanisms of the different DNA adduct forming potentials of the urban air pollutants 2-nitrobenzanthrone and carcinogenic 3-nitrobenzanthrone. Chem. Res. Toxicol. 23, 1192–1201. PubMed
Umannova L., Machala M., Topinka J., Novakova Z., Milcova A., Kozubik A., Vondracek J. (2008). Tumor necrosis factor-alpha potentiates genotoxic effects of benzo[a]pyrene in rat liver epithelial cells through upregulation of cytochrome P450 1B1 expression. Mutat. Res. 640, 162–169. PubMed
Vogel C. F., Khan E. M., Leung P. S., Gershwin M. E., Chang W. L., Wu D., Haarmann-Stemmann T., Hoffmann A., Denison M. S. (2014). Cross-talk between aryl hydrocarbon receptor and the inflammatory response: a role for nuclear factor-kappaB. J. Biol. Chem. 289, 1866–1875. PubMed PMC
Vondracek J., Umannova L., Machala M. (2011). Interactions of the aryl hydrocarbon receptor with inflammatory mediators: beyond CYP1A regulation. Curr. Drug Metab. 12, 89–103. PubMed
Walser T., Cui X., Yanagawa J., Lee J. M., Heinrich E., Lee G., Sharma S., Dubinett S. M. (2008). Smoking and lung cancer: the role of inflammation. Proc. Am. Thorac. Soc. 5, 811–815. PubMed PMC
Wang T., Gavin H. M., Arlt V. M., Lawrence B. P., Fenton S. E., Medina D., Vorderstrasse B. A. (2011). Aryl hydrocarbon receptor activation during pregnancy, and in adult nulliparous mice, delays the subsequent development of DMBA-induced mammary tumors. Int. J. Cancer 128, 1509–1523. PubMed PMC
Warren G. W., Poloyac S. M., Gary D. S., Mattson M. P., Blouin R. A. (1999). Hepatic cytochrome P-450 expression in tumor necrosis factor-alpha receptor (p55/p75) knockout mice after endotoxin administration. J. Pharmacol. Exp. Ther. 288, 945–950. PubMed
Wu D., Li W., Lok P., Matsumura F., Vogel C. F. (2011). AhR deficiency impairs expression of LPS-induced inflammatory genes in mice. Biochem. Biophys. Res. Commun. 410, 358–363. PubMed PMC
Zordoky B. N., El-Kadi A. O. (2009). Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr. Drug Metab. 10, 164–178. PubMed